2018
Over the last ten years, we have conducted research in Alzheimer’s disease (AD) using multimodal neuroimaging techniques to improve diagnosis, (…)
Consulter 
2018
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer’s disease (AD), but its prevalence is unclear because (…)
Consulter
2019
Multimodal neuroimaging analyses offer additional information beyond that provided by each neuroimaging modality. Thus, direct comparisons and correlations between neuroimaging (…)
Consulter
2018
Patients with amnestic mild cognitive impairment (aMCI) are heterogeneous as regard to their amyloid status. The present study aimed at (…)
Consulter
2018
Consulter
2020
Several concepts, which in the aggregate get might be used to account for "resilience" against age- and disease-related changes, have (…)
Consulter
